Symposium - European Medical Journal

Continue

Symposiums

EMJ Cardiology 8 [Supplement 4] 2020 Feature Image
Cardiology
8 Mins
22 Dec 2020

Long-Term Benefits of a Holistic Approach on Dyslipidaemia Management

Prof Banach explained that current lipid-lowering therapy (LLT) with statins, ezetimibe, and proprotein convertase subtilisin/kexin Type 9 inhibitors…
Allergy & Immunology
11 Mins
22 Dec 2020

Human Milk Oligosaccharides: New Developments in the Management of Cow’s Milk Protein Allergy

This symposium, which was part of the industry programme at Food Allergy and Anaphylaxis Meeting and the European Consortium on Application…
EMJ Oncology 8 [Supplement 4] 2020 Feature Image
Oncology
6 Mins
16 Dec 2020

3rd Breast Cancer Virtual Masterclass Symposium: MONARCH 2, a Phase III Study of Abemaciclib or Placebo in Combination with Fulvestrant

More than 70% of patients diagnosed with metastatic breast cancer present with oestrogen-HR+ disease and are therefore candidates for endocrine…
Dermatology
8 Mins
15 Dec 2020

The Other Side of the Moon: A Clinical Dialogue on the IL-23 Pathway

Prof Reich began by highlighting how insights into the pathophysiology of psoriasis have led to the development and expansion of cytokine-targeted…
Derm 8.1 feature image
Dermatology
6 Mins
15 Dec 2020

Latest Highlights on Biologic Treatments for Psoriasis and Psoriatic Arthritis from EADV 2020

The VOYAGE 1 trial1 was a placebo- and active-controlled Phase III study to evaluate long-term efficacy and safety of the IL-23p19 inhibitor guselkumab…
Derm 8.1 feature image
Dermatology
8 Mins
15 Dec 2020

Bimekizumab Efficacy and Safety in Patients with Moderate-to-Severe Plaque Psoriasis

Psoriasis is a Th17-driven disease, with both IL-17A and IL-17F playing a pivotal role in its pathogenesis.2,3 BKZ is a monoclonal IgG1 antibody…
Cardiology
7 Mins
14 Dec 2020

Looking PHorward to Improving Long-Term Outcomes in Pulmonary Arterial Hypertension

PH encompasses a heterogeneous group of conditions, including PAH (Group 1), PH due to LHD (Group 2), PH due to lung diseases and/or hypoxia…
EMJ 5 [Supplement 1] 2020 Feature Image
Respiratory
7 Mins
14 Dec 2020

The Lung, at the Heart of Pulmonary Arterial Hypertension

The objectives of this symposium were firstly to recognise the difficult diagnostic journey faced by patients with PAH, to learn expert tips on how…
We’ve noticed you’re accessing
from North/South America.